To determine the safety and efficacy of a single dose of solithromycin (CEM-101) for the
treatment of uncomplicated urogenital gonorrhea.
Drug: Solithromycin (CEM-101)
We will connect you to the doctor responsible for this trial and help you get more information.
Locations near you
Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Full eligibility criteria for NCT01591447
Ages eligible for Study
19 Years and older
Genders eligible for Study
Accepts Healthy Volunteers
Evidence of a urogenital gonococcal infection (prior culture, NAAT test, Gram stain, sexual contact)
Willing to abstain from anal, oral, or vaginal sexual intercourse or use condoms until study completion.
Females of childbearing potential (including females less than 2 years post-menopausal) must have a negative pregnancy test at enrollment.
Confirmed, or suspected, complicated or systemic gonococcal infections such as pelvic inflammatory disease, arthritis, or endocarditis.
Known HIV, chronic hepatitis B, or hepatitis C infection.
Known concomitant infection which would require additional systemic antibiotics.
Use of systemic or intravaginal antibiotics within 30 days prior to study drug administration.
Current use of corticosteroid drugs or other immunosuppressive therapy.
Cytotoxic chemotherapy or radiation therapy within the previous 3 months.
Known significant renal, hepatic, or hematologic impairment.
History of intolerance or hypersensitivity to macrolide antibiotics.
Any concomitant condition that, in the opinion of the Investigator, would preclude an evaluation of a response or make it unlikely that the contemplated course of therapy and follow-up could be completed (e.g., life expectancy <30 days).
All locations for NCT01591447
United States (2)
Jefferson County Department of Health
Birmingham, Alabama, United States, 35233
Harborview STD Clinic
Seattle, Washington, United States, 98104
View full eligibility
Tris trial is registered with FDA with number: NCT01591447. The sponsor of the trial is Melinta Therapeutics, Inc. and it is looking for 60 volunteers for the current phase.
Official trial title: An Open-Label Study to Evaluate the Efficacy and Safety of a Single-Dose of Oral CEM-101 in the Treatment of Male and Female Patients With Uncomplicated Urogenital Gonorrhea
1What's a trial
4Get in touch
What's a trial
Not sure you're well informed about clinical trials? Learn more about their benefits, risks and other important details.
Enter your details like condition, age, gender and other preferences and we will show you a list of all relevant clinical trials.
Review the summary of the selected clinical trial and all the locations near you in order to see if it's of interest to you.
Get in touch
You've found an interesting trial? We'll need a bit more information about you so we can connect you to the doctor in charge.
Some people want to consult their doctor before considering participation in a clinical trial. This is absolutely normal as your doctor should know your medical history and should be able to advise you. If you want you can easily share the information for this trial with your doctor by clicking on the button below.